Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00071656 |
Recruitment Status
:
Completed
First Posted
: October 30, 2003
Last Update Posted
: August 9, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Attention Deficit Disorder With Hyperactivity | Behavioral: Psychosocial (behavioral) Intervention | Not Applicable |
ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed.
Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Primary Purpose: | Treatment |
Official Title: | Psychosocial Treatment for ADHD Inattentive Type I |
Study Start Date : | September 2002 |
Actual Study Completion Date : | June 2007 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 7 Years to 11 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ADHD, Predominantly Inattentive Type
- Public or private school attendance
- English speaking

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00071656
United States, California | |
HALP Clinic, Children's Center at Langley Porter, UCSF | |
San Francisco, California, United States, 94143 |
ClinicalTrials.gov Identifier: | NCT00071656 History of Changes |
Other Study ID Numbers: |
R21MH065927 ( U.S. NIH Grant/Contract ) DSIR CT-S |
First Posted: | October 30, 2003 Key Record Dates |
Last Update Posted: | August 9, 2013 |
Last Verified: | August 2013 |
Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders |
Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms |